Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and Vitamin K antagonists for treatment and secondary prevention of venous thromboembolism
- Elías, I.
- Oyagüez, I.
- Álvarez-Sala, L.A.
- García-Bragado, F.
- Navarro, A.
- González, P.
- De Andrés-Nogales, F.
- Soto, J.
ISSN: 2171-8695, 1130-6343
Year of publication: 2016
Volume: 40
Issue: 3
Pages: 187-208
Type: Review